[go: up one dir, main page]

IE47545B1 - N-cyano-n'-alkynyl-n"-(2-mercaptoethyl)-guanidines - Google Patents

N-cyano-n'-alkynyl-n"-(2-mercaptoethyl)-guanidines

Info

Publication number
IE47545B1
IE47545B1 IE2933/81A IE293381A IE47545B1 IE 47545 B1 IE47545 B1 IE 47545B1 IE 2933/81 A IE2933/81 A IE 2933/81A IE 293381 A IE293381 A IE 293381A IE 47545 B1 IE47545 B1 IE 47545B1
Authority
IE
Ireland
Prior art keywords
compound
cyano
mercaptoethyl
formula
ncn
Prior art date
Application number
IE2933/81A
Other versions
IE812933L (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/848,959 external-priority patent/US4112234A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Priority claimed from IE1112/78A external-priority patent/IE47543B1/en
Publication of IE812933L publication Critical patent/IE812933L/en
Publication of IE47545B1 publication Critical patent/IE47545B1/en

Links

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Description

The present invention relates to certain N-cyano-N' alkynyl-N"-(2-mercaptoethyl)-guanidines which are intermediates useful in the preparation of certain N-cyano-N*[2-[(4-methyl-5-imidazolyl)methylthio] -ethyl] -N-alkynyl guanidines which are receptor blocking agents, which inhibit gastric acid secretion and which are useful in the treatment of ulcers.
Accordingly, the present invention provides a compound of the formula: NCN HSCH2CH2NHCNH —R‘ ,1 (III) wherein R^ is a straight or branched chain alkynyl group containing from 3 to 9 carbon atoms.
In a preferred embodiment, R^ of the compound of formula III is in which R is hydrogen or methyl? in another preferred embodiment R^ is -(CH2) C = CR in which n is an integer 4 " of from 1 to 6 and R is hydrogen or methyl? and in still another preferred embodiment R^ is —C— CSCE4 I ch3 in which R is hydrogen or methyl.
In a more preferred embodiment, R1 of the compound of Formula III is a 2-butyn-l-yl, 3-butyn-l-yl, 4-pentyn5 1-yl, 2-methyl-3-butyn-2-yl or 3-butyn-2-yl group.
The compounds of the present invention are intermediates in the preparation of compounds of the formula: XCH3 H NCN II 1 CH2 SCH2CH2NHCNH-R wherein R1 is a straight or branched chain alkynyl group 10 containing from 3 to 9 carbon atoms.
The compounds of Formula I are described and claimed in Patent Specification No. 47543.
The compounds of Formula I may be prepared by reacting a compound of the formula: II or an acid addition salt thereof, in which X is hydroxy or a leaving group with a compound of the formula: NCN Ί 1 HSCH2CH NHCNH-R iii • 47545 wherein R^ is as above defined.
This process is illustrated, by way of example, by the following reaction scheme: CH3 NCN II + HSCH2CH2NHCNHCH2C = CH 'Nz H ch2oh/h CH„ NCN 'CH2SCH2CH2NHCNHCH2C == CH The compounds of the present invention may be prepared by reacting a compound of the formula: p-sch2ch2nh2 IV wherein P is a mercapto protecting group with a compound of the formula: NCN II 1 RSCNHR wherein -SR is a leaving group, and thereafter removing the protecting group P from the resulting compound to produce the compound of the invention.
This process is illustrated by the scheme given below: 475 NCN II PSCH2CH2NH2+RSCNHCH2C = CH 1) Heat 2) Deprotect NCN ll HSCH2CH2NHCNHCH2C sCH The present invention will be further described with reference to the following Examples.
EXAMPLE 1 N-Cyano-N'-propargyl-N-(2-mercaptoethyl)guanidine N-Cyano-N1-propar gyl-S-methylisothiourea (A) A solution of dimethyl cyanodithioiminocarbonate (16.00 g, 0.109 mole) and propargylamine (6.03 g, 0.109 mole) in acetonitrile (320 ml) was stirred at reflux for 4 hours, and then at 25°C for 12 hours. The mixture was cooled and filtered to yield N-cyano-N1-propargyl-S-methyl isothiourea.
N-Cyano-N' -propargyl-N-(2-mercaptoethyl) guanidine (B) A mixture of 1.136 g (10 m moles) of cysteamine hydrochloride, 1.53 g (10 m moles) of the product of step (A) above, and 0.055 g of hydroquinone in 10 ml DMF was slightly warmed to dissolve the compounds therein. To this solution was added 10 ml of an aqueous sodium hydroxide and nitrogen was bubbled through the solution.
After standing at room temperature for 17 hours, the reaction mixture was evaporated to dryness to give a mixture of the title product and sodium chloride. The title product was extracted from this mixture with 10 ml ethanol.
EXAMPLE 2 N-Cyano-Ν'- (2 -butyn-l-yl,) -N - (2 -mercaptoethyl) -guanidine N-Cyano-N-(2-butyn-l-yl)-S-methylisothiourea (A) A solution of dimethyl cyanodithioiminocarbonate (10.00 g, 0.0684 mole) and 2-butyn-l-ylamine (4.73 g, 0.0684 mole) in acetonitrile (200 ml) was stirred at 25°C for 0.5 hour, and then at reflux for 2.5 hours. The mixture was cooled and filtered to yield N-cyano-N'-(2butyn-l-yl)-S-methylisothiourea.
N-Cyano-N' -(2-butyn-1-yl) -N - (2-mercaptoethyl) guanidine (B) The general procedure of Example 1 (B) was repeated except that the N-cyano-N1-pxopargyl-S-methylisothiourea utilized therein is replaced by an equimolar amount of N-cyano-N'-{2-butyn-l-yl)-S-methylisothiourea, and the title product is thereby produced.
EXAMPLE 3 N-Cyano-Ν'-(3-butyn-l-yl)-N-(2-mercaptoethyl)-guanidine The general procedures of Example 1 steps A and B are repeated except that the propargylamine utilized in step A thereof is replaced by an equimolar amount of 3- butyn-1-ylamine, and the title compound is thereby produced.
EXAMPLE 4 N-Cyano-Ν'-(4-pentyn-l-yl)-N-(2-mercaptoethyl)-guanidine The general procedures of Example 1 steps A and B are repeated except that the propargylamine utilized in step A thereof is replaced by an equimolar amount of 4- pentyn-l-ylamine, and the title compound is thereby produced. - 7 EXAMPLE 5 N-Cyano-N'-(2-methyl-3-butyn-2-yl)-N-(2-mercaptoethyl)guanidine The general procedures of Example 1 steps A and B are repeated except that the propargylamine utilized in step A thereof is replaced by an equimolar amount of 1,1dimethylpropargylamine, and the title compound is thereby produced.
EXAMPLE 6 N-Cyano-N'-(3-butyn-2-yl)-N-(2-mercaptoethyl) guanidine The general procedures of Example 1 steps A and B are repeated except that the propargylamine utilized in step A thereof is replaced by an equimolar amount of 1ine thyl-propargylamine, and the title compound is thereby produced.
Patent Specification No. 47544 describes and claims compounds of the formulae NCN II 1 RZS-CNH-RX 2 . wherein R is as above defined and R is C. alkyl, aryl, j.—y substituted aryl, aralkyl, -CH2CN, -CH2COOH or -C^COOR' wherein R' is c^_g lower alkyl.

Claims (9)

1. CLAIMS:1. A compound of the general formula: NCN HSCH 2 CH 2 NHCNH-R wherein R 1 is a straight or branched chain alkynyl group containing from 3 to 9 carbon atoms.
2. . A compound as claimed in claim 1 wherein R^ is -CHCseCR CH_ wherein R is H or CH . 3 1
3. A compound as claimed xn claim 1 wherein R is -(CH ) C—CR^ 2 n wherein R is H or CH^ and n is an integer of from 1 to 6, inclusive.
4. A compound as claimed in claim 1 wherein R^ is CH 3 I 1 4 — C-CSCR CH„ 15 wherein R is H or CH^.
5. A compound as claimed in claim 2 or claim 3 . 4 . wherexn R is H.
6. A compound as claimed in claim 2 or claim 3 4 wherein R is CH^. 20
7. A process for the preparation of a compound as claimed in claim 1 which process comprises reacting a compound of the formula: P-SCH 2 CH 2 NH 2 IV wherein P is a mercapto protecting group with a compound of the formula: NCN II RSCNHR’ ,1 5 wherein SR is a leaving group, and thereafter removing the protecting group P from the resulting compound.
8. A process for preparing a compound as claimed in claim 1 substantially as hereinbefore described with reference to any one of the Examples.
9. 10 9. A compound as claimed in claim 1 whenever prepared by a process as claimed in claim 7 or claim 8.
IE2933/81A 1977-06-03 1978-06-02 N-cyano-n'-alkynyl-n"-(2-mercaptoethyl)-guanidines IE47545B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US80300977A 1977-06-03 1977-06-03
US82679677A 1977-08-22 1977-08-22
US05/848,959 US4112234A (en) 1977-08-22 1977-11-07 Imidazolylmethylthioethyl alkynyl guanidines
IE1112/78A IE47543B1 (en) 1977-06-03 1978-06-02 Guanidine derivatives

Publications (2)

Publication Number Publication Date
IE812933L IE812933L (en) 1978-12-03
IE47545B1 true IE47545B1 (en) 1984-04-18

Family

ID=27452041

Family Applications (2)

Application Number Title Priority Date Filing Date
IE2933/81A IE47545B1 (en) 1977-06-03 1978-06-02 N-cyano-n'-alkynyl-n"-(2-mercaptoethyl)-guanidines
IE2932/81A IE47544B1 (en) 1977-06-03 1978-06-02 N-cyano-n'-alkynyl-s-substituted isothioureas

Family Applications After (1)

Application Number Title Priority Date Filing Date
IE2932/81A IE47544B1 (en) 1977-06-03 1978-06-02 N-cyano-n'-alkynyl-s-substituted isothioureas

Country Status (1)

Country Link
IE (2) IE47545B1 (en)

Also Published As

Publication number Publication date
IE812932L (en) 1978-12-03
IE812933L (en) 1978-12-03
IE47544B1 (en) 1984-04-18

Similar Documents

Publication Publication Date Title
EP0125919A3 (en) Catechol derivatives, their production and intermediates therefor, and pharmaceutical compositions containing them
US5322858A (en) N,N'-substituted imidodicarbonimidic diamides derived from hydroxylamines
HU192664B (en) Process for producing antirheumaticmet methylene-diphosphonic acid derivatives
MX9603004A (en) Cyanic acid substituted guanidines, process for their preparation, their employment as medicament or diagnosis agent, as well as medicaments containing them.
US6160167A (en) Mercaptans and disulfides
EP0054936B1 (en) Aroyl amino acids
GB1598630A (en) N-cyano-n'-alkynyl-n''-(2-mercaptoethyl)-guanidines
IE47545B1 (en) N-cyano-n'-alkynyl-n"-(2-mercaptoethyl)-guanidines
CA1118445A (en) N,n'-[bis(n-cyanoguanyl)] crystamine derivatives
US4158013A (en) N-Cyano-N'-alkynyl-N"-2-mercaptoethylguanidines
DK1213279T3 (en) Process for the preparation of venlafaxine
SU1122222A3 (en) Method of obtaining cymetidine
HU199113B (en) Process for production of new derivatives of 2,3-diamin-acryl-acid-nitril
KR830007510A (en) Method of manufacturing heart disease treatment
KR850001173A (en) Method for preparing 2-substituted 4-phenylimidazole amidine derivatives
GB2102791A (en) Alkynylamino ethylenes
KR940009935B1 (en) N-benzoyl-c-thiophenoxyimidoyl chloride derivatives and manufacturing method thereof
SU650991A1 (en) Plant growth regulator
KR920021496A (en) Amide derivatives, preparation method thereof and compositions for inhibiting pests
KR930007910A (en) N-methoxyphenylethyl-N'-imidazolylphenylamidine derivatives and preparation method thereof
ATE249434T1 (en) A METHOD FOR PRODUCING PYRROLIDINONE DERIVATIVES
KR840000071B1 (en) Preparation of N-cyano-N'-methyl-N "[2-((methyl-5-imidazolyl) methylthio) ethyl] guanidine
NZ200923A (en) Cystine derivatives and pharmaceutical compositions containing such
KR890002250B1 (en) Process for preparing triazine derivatives
IT1173206B (en) PROCEDURE FOR THE PREPARATION OF N- (DIBENZYLSYPHOSPHORYL) CYANAMIDE, COMPOUND SO OBTAINED, PROCESSES THAT USE THIS COMPOUND AS INTERMEDIATE SYNTHESIS OF PHOSPHAGEN SUBSTANCES AND SUBSTANCES IN SUCH A WAY PRODUCED